Clinical manifestations of intermediate allele carriers in Huntington disease.
Insulin-Like Growth Factor-1 but Not Insulin Predicts Cognitive Decline in Huntington's Disease.
Brain 18F-FDG PET Metabolic Abnormalities in Patients with Long-Lasting Macrophagic Myofascitis.
Rating scales for Cognition in Huntington's disease: Critique and recommendations
A randomized, double-blind, placebo-controlled trial evaluating cysteamine in Huntington's disease.
From open to large-scale randomized cell transplantation trials in Huntington's disease: Lessons from the multicentric intracerebral grafting in Huntington's disease trial (MIG-HD) and previous pilot studies.
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.
Cognitive dysfunction associated with aluminum hydroxide-induced macrophagic myofasciitis: A reappraisal of neuropsychological profile.
Rating scales for cognition in Huntington's disease: Critique and recommendations.
Motor and cognitive improvements in patients with Huntington’s disease after neural transplantation